is glp 1 gila monster venom A venomous lizard that eats only 5 times a year created today's most effective obesity dugs. The secret to the world's most popular weight-loss drug hidden in the venomous saliva of In the 1980s, researchers at

Ginseng Tea for Energy and Vitality Ginseng supports natural energy and stamina without caffeine

An improvement in fibrosis stage was seen in 43% of the higher dose semaglutide group versus 33% of the patients in the placebo group but this was not statistically significant

This leads to: Excessive muscle loss Fatigue and weakness Hair thinning or shedding (telogen effluvium) Nutrient deficiencies Metabolic slowdown How to prevent this: Track protein intake (minimum 0.7g per pound of body weight daily) Eat protein first at every meal Use protein shakes if whole food feels too filling Dont let the medication be an excuse to skip meals Dehydration: Reduced food intake often means reduced fluid intake

Preclinical studies have identified that GLP-1 analogs such as exendin-4 and GLP-1RAs have direct anti-atherosclerotic and anti-inflammatory effects that may contribute to their cardio- and neuroprotective nature.[42] GLP-1RAs can also directly interact with cardiomyocytes, inducing receptor-mediated ischemic conditioning that decreases myocardial infarct size in test animals receiving GLP-1RAs.[43] Similar effects were noted in rodent brains, with liraglutide reducing cerebral infarct volume in rats.[42] Randomized clinical trials (RCTs) also identified that exenatide similarly reduced myocardial infarct size and liraglutide reduced the resulting necrotic area in human patients following a MI.[43] This may account for the reduced need for coronary revascularization in patients on GLP-1RAs.[12] Despite the findings of overall improvements to composite cardiovascular outcomes, GLP-1RAs showed a non-significant trend toward reducing MI risk and did not affect rates of hospitalization for unstable angina in patients with diabetes.[12] These agents tend to have a stronger effect on stroke reduction in such patients, highlighting the complexity and variability of cardiovascular disease and its sequelae

Postoperative Use of GLP-1 Agonists For some patients, weight regain is a concern after bariatric surgery

(See next question.) How is a prescription handled